The ideal candidate for medically assisted weight loss is an individual with a BMI of 27 or higher who is looking to manage obesity or weight-related health conditions, such as diabetes or hypertension
However, it is unsuitable for those with familial or personal histories of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
Insulin resistance Ozempic is designed to treat people with diabetes and help them lower their A1C
Are compounded semaglutide or tirzepatide safe
Additionally, co-administration of probiotics with standard treatments, such as surgery, chemotherapy, and immunotherapy, may help ameliorate treatment-associated adverse events, augment therapeutic efficacy, and improve overall patient quality of life
GLP-1 receptor agonists may reduce symptoms of depression